ArticleJournal of experimental & clinical cancer research : CR2024

Targeting mTOR and survivin concurrently potentiates radiation therapy in renal cell carcinoma by suppressing DNA damage repair and amplifying mitotic catastrophe.

Hari K Rachamala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.